Difference in the expression of inflammatory mediators in gingival crevicular fluid in postmenopausal patients with chronic periodontitis with and without menopausal hormone therapy

Objective: Hormonal changes experience by women produce significant changes in the periodontium. The aim of this study is to assess whether menopausal hormone therapy, in patients diagnosed with moderate chronic periodontitis and menopause presents a beneficial effect, in terms of clinical and immun...

Full description

Bibliographic Details
Main Authors: Santiago Arias-Herrera, Cristina Bascones-Ilundian, Antonio Bascones-Martínez
Format: Article
Language:English
Published: Elsevier 2019-07-01
Series:European Journal of Obstetrics & Gynecology and Reproductive Biology: X
Online Access:http://www.sciencedirect.com/science/article/pii/S2590161319300560
id doaj-a3d78fb14fe847a7b067d3bf10d69ac7
record_format Article
spelling doaj-a3d78fb14fe847a7b067d3bf10d69ac72020-11-25T00:17:26ZengElsevierEuropean Journal of Obstetrics & Gynecology and Reproductive Biology: X2590-16132019-07-013Difference in the expression of inflammatory mediators in gingival crevicular fluid in postmenopausal patients with chronic periodontitis with and without menopausal hormone therapySantiago Arias-Herrera0Cristina Bascones-Ilundian1Antonio Bascones-Martínez2Corresponding author at: Plaza Ramon y Cajal, 3, 28040, Madrid, Spain.; Department of Periodontology, Host Response in Oral Pathology (HROP) Research Group, Complutense University, Madrid, SpainDepartment of Periodontology, Host Response in Oral Pathology (HROP) Research Group, Complutense University, Madrid, SpainDepartment of Periodontology, Host Response in Oral Pathology (HROP) Research Group, Complutense University, Madrid, SpainObjective: Hormonal changes experience by women produce significant changes in the periodontium. The aim of this study is to assess whether menopausal hormone therapy, in patients diagnosed with moderate chronic periodontitis and menopause presents a beneficial effect, in terms of clinical and immunological outcomes. Study design: Thirty subjects with moderate chronic periodontitis and menopause were selected and assigned to two groups in accordance to the presence of menopausal hormone therapy. Periodontal clinical parameters, microbiological samples and immunological variables were assessed in both groups. Inter-group differences were evaluated using non-paired Student t-tests and chi square tests. Also, Pearson coefficient correlation was performed to determine the correlation between variables. Results: There were statistically significant differences between groups for clinical attachment level, probing pocket depth, interleukin 1β and interleukin 6. Smoking habit, deeper PPD and higher Il-6 levels in non-menopausal hormone therapy users group, tend to increase the interleukin 1ß GCF levels. These findings were supported by serum estrogen levels. The variables levels were higher in the menopausal hormone therapy users group. Conclusion: Within the limitations of the present study, the hypothesis that menopausal hormone therapy user’s women will show better periodontal status and differences in immunological variables respect to those being non-menopausal hormone therapy users was supported. Keywords: Menopause, Estrogen therapy, Interleukin, Periodontal diseases, Chronic periodontitishttp://www.sciencedirect.com/science/article/pii/S2590161319300560
collection DOAJ
language English
format Article
sources DOAJ
author Santiago Arias-Herrera
Cristina Bascones-Ilundian
Antonio Bascones-Martínez
spellingShingle Santiago Arias-Herrera
Cristina Bascones-Ilundian
Antonio Bascones-Martínez
Difference in the expression of inflammatory mediators in gingival crevicular fluid in postmenopausal patients with chronic periodontitis with and without menopausal hormone therapy
European Journal of Obstetrics & Gynecology and Reproductive Biology: X
author_facet Santiago Arias-Herrera
Cristina Bascones-Ilundian
Antonio Bascones-Martínez
author_sort Santiago Arias-Herrera
title Difference in the expression of inflammatory mediators in gingival crevicular fluid in postmenopausal patients with chronic periodontitis with and without menopausal hormone therapy
title_short Difference in the expression of inflammatory mediators in gingival crevicular fluid in postmenopausal patients with chronic periodontitis with and without menopausal hormone therapy
title_full Difference in the expression of inflammatory mediators in gingival crevicular fluid in postmenopausal patients with chronic periodontitis with and without menopausal hormone therapy
title_fullStr Difference in the expression of inflammatory mediators in gingival crevicular fluid in postmenopausal patients with chronic periodontitis with and without menopausal hormone therapy
title_full_unstemmed Difference in the expression of inflammatory mediators in gingival crevicular fluid in postmenopausal patients with chronic periodontitis with and without menopausal hormone therapy
title_sort difference in the expression of inflammatory mediators in gingival crevicular fluid in postmenopausal patients with chronic periodontitis with and without menopausal hormone therapy
publisher Elsevier
series European Journal of Obstetrics & Gynecology and Reproductive Biology: X
issn 2590-1613
publishDate 2019-07-01
description Objective: Hormonal changes experience by women produce significant changes in the periodontium. The aim of this study is to assess whether menopausal hormone therapy, in patients diagnosed with moderate chronic periodontitis and menopause presents a beneficial effect, in terms of clinical and immunological outcomes. Study design: Thirty subjects with moderate chronic periodontitis and menopause were selected and assigned to two groups in accordance to the presence of menopausal hormone therapy. Periodontal clinical parameters, microbiological samples and immunological variables were assessed in both groups. Inter-group differences were evaluated using non-paired Student t-tests and chi square tests. Also, Pearson coefficient correlation was performed to determine the correlation between variables. Results: There were statistically significant differences between groups for clinical attachment level, probing pocket depth, interleukin 1β and interleukin 6. Smoking habit, deeper PPD and higher Il-6 levels in non-menopausal hormone therapy users group, tend to increase the interleukin 1ß GCF levels. These findings were supported by serum estrogen levels. The variables levels were higher in the menopausal hormone therapy users group. Conclusion: Within the limitations of the present study, the hypothesis that menopausal hormone therapy user’s women will show better periodontal status and differences in immunological variables respect to those being non-menopausal hormone therapy users was supported. Keywords: Menopause, Estrogen therapy, Interleukin, Periodontal diseases, Chronic periodontitis
url http://www.sciencedirect.com/science/article/pii/S2590161319300560
work_keys_str_mv AT santiagoariasherrera differenceintheexpressionofinflammatorymediatorsingingivalcrevicularfluidinpostmenopausalpatientswithchronicperiodontitiswithandwithoutmenopausalhormonetherapy
AT cristinabasconesilundian differenceintheexpressionofinflammatorymediatorsingingivalcrevicularfluidinpostmenopausalpatientswithchronicperiodontitiswithandwithoutmenopausalhormonetherapy
AT antoniobasconesmartinez differenceintheexpressionofinflammatorymediatorsingingivalcrevicularfluidinpostmenopausalpatientswithchronicperiodontitiswithandwithoutmenopausalhormonetherapy
_version_ 1725379820656787456